{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:03:25Z","timestamp":1765667005772},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/hco.0b013e3283587c7e","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T10:24:33Z","timestamp":1350383073000},"page":"634-641","source":"Crossref","is-referenced-by-count":20,"title":["Very late stent thrombosis"],"prefix":"10.1097","volume":"27","author":[{"given":"Omar K.","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Faxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/hc3101.092214","article-title":"Physiological transport forces govern drug distribution for stent-based delivery.","volume":"104","author":"Hwang","year":"2001","journal-title":"Circulation"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents.","volume":"354","author":"Serruys","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/01.CIR.103.15.1967","article-title":"Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.","volume":"103","author":"Cutlip","year":"2001","journal-title":"Circulation"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.105.609057","article-title":"Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.","volume":"116","author":"Awata","year":"2007","journal-title":"Circulation"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.","volume":"119","author":"van Werkum","year":"2009","journal-title":"Circulation"},{"key":"R12-12-20210204","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2007.10.057","article-title":"Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos).","volume":"51","author":"de la Torre-Hernandez JM, Alfonso","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"581e1","DOI":"10.1016\/j.amjmed.2008.12.019","article-title":"Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.","volume":"122","author":"Roukoz","year":"2009","journal-title":"Am J Med"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.111.046599","article-title":"Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.","volume":"125","author":"Kimura","year":"2012","journal-title":"Circulation"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.amjcard.2011.07.004","article-title":"Stent-related cardiac events beyond three years after implantation of the sirolimus-eluting stent (from the EVASTENT Patients).","volume":"108","author":"Barone-Rochette","year":"2011","journal-title":"Am J Cardiol"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.","volume":"52","author":"Wenaweser","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCINTERVENTIONS.108.844985","article-title":"Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry.","volume":"2","author":"Lagerqvist","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4244\/EIJV5I8A153","article-title":"Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.","volume":"5","author":"Jensen","year":"2010","journal-title":"EuroIntervention"},{"key":"R20-12-20210204","first-page":"401","article-title":"Incidence and predictors of very late (or =4 years4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-LATE registry.","volume":"2","author":"Costa","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ccd.22533","article-title":"Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents for the percutaneous treatment of stable coronary artery disease.","volume":"76","author":"Simsek","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2009.04.077","article-title":"5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.","volume":"54","author":"Caixeta","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.","volume":"172","author":"De Luca","year":"2012","journal-title":"Arch Intern Med"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacc.2011.02.023","article-title":"2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial).","volume":"58","author":"Smits","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jacc.2011.01.023","article-title":"Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization.","volume":"57","author":"Raber","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","article-title":"Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug ABT-578 Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).","volume":"4","author":"Kandzari","year":"2011","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2011.03.005","article-title":"Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial.","volume":"57","author":"Yeung","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(11)60395-4","article-title":"Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.","volume":"377","author":"Silber","year":"2011","journal-title":"Lancet"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1155\/2012\/956962","article-title":"Stent thrombosis: incidence, predictors and new technologies.","volume":"2012","author":"Buchanan","year":"2012","journal-title":"Thrombosis"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1540-8183.2009.00466.x","article-title":"Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents.","volume":"22","author":"Lemesle","year":"2009","journal-title":"J Interv Cardiol"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.jacc.2008.01.070","article-title":"ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients.","volume":"51","author":"Chechi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ahj.2009.12.032","article-title":"The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction.","volume":"159","author":"Ergelen","year":"2010","journal-title":"Am Heart J"},{"key":"R34-12-20210204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","article-title":"Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis.","volume":"5","author":"Armstrong","year":"2012","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"R35-12-20210204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.903955","article-title":"Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).","volume":"122","author":"Kimura","year":"2010","journal-title":"Circulation"},{"key":"R36-12-20210204","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1253\/circj.CJ-08-0732","article-title":"Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS).","volume":"73","author":"Ikari","year":"2009","journal-title":"Circ J"},{"key":"R37-12-20210204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000149571","article-title":"Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.","volume":"112","author":"Zhu","year":"2009","journal-title":"Cardiology"},{"key":"R38-12-20210204","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.111.079731","article-title":"Very late stent thrombosis and late target lesion revascularization: no end in sight.","volume":"125","author":"Faxon","year":"2012","journal-title":"Circulation"},{"key":"R39-12-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R40-12-20210204","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.jacc.2009.10.077","article-title":"Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation.","volume":"55","author":"Lee","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R41-12-20210204","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","article-title":"Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.","volume":"47","author":"Kotani","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R42-12-20210204","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","article-title":"Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"R43-12-20210204","doi-asserted-by":"crossref","first-page":"219389","DOI":"10.1155\/2012\/219389","article-title":"Pathological perspective of drug-eluting stent thrombosis.","volume":"2012","author":"Inoue","year":"2012","journal-title":"Thrombosis"},{"key":"R44-12-20210204","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCULATIONAHA.110.963181","article-title":"Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.","volume":"123","author":"Guagliumi","year":"2011","journal-title":"Circulation"},{"key":"R45-12-20210204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCULATIONAHA.109.854398","article-title":"Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.","volume":"120","author":"Cook","year":"2009","journal-title":"Circulation"},{"key":"R46-12-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCINTERVENTIONS.109.854679","article-title":"Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima.","volume":"2","author":"Yokoyama","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"R47-12-20210204","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcmg.2008.12.026","article-title":"Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.","volume":"2","author":"Higo","year":"2009","journal-title":"J Am Coll Cardiol Cardiovasc Imag"},{"key":"R48-12-20210204","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1161\/CIRCULATIONAHA.110.988436","article-title":"Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.","volume":"123","author":"Kang","year":"2011","journal-title":"Circulation"},{"key":"R49-12-20210204","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R50-12-20210204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCINTERVENTIONS.111.964965","article-title":"Bare metal stent thrombosis and in-stent neoatherosclerosis.","volume":"5","author":"Yamaji","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R52-12-20210204","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"R53-12-20210204","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2008.10.007","article-title":"Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.","volume":"124","author":"Wang","year":"2008","journal-title":"Thromb Res"},{"key":"R54-12-20210204","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-05-0284","article-title":"Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.","volume":"103","author":"Sibbing","year":"2010","journal-title":"Thromb Haemost"},{"key":"R55-12-20210204","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/heartjnl-2011-301164","article-title":"Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry.","volume":"98","author":"Sambu","year":"2012","journal-title":"Heart"},{"key":"R57-12-20210204","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCINTERVENTIONS.111.967257","article-title":"Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the veterans administration drug-eluting stent study.","volume":"5","author":"Faxon","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R58-12-20210204","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.","volume":"53","author":"van Werkum","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R59-12-20210204","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4244\/EIJV7I7A125","article-title":"The three year follow-up of the randomised all-comers trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).","volume":"7","author":"Wykrzykowska","year":"2011","journal-title":"EuroIntervention"},{"key":"R60-12-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/eurheartj\/ehp480","article-title":"An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.","volume":"31","author":"Barlis","year":"2010","journal-title":"Eur Heart J"},{"key":"R61-12-20210204","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.","volume":"59","author":"Meredith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R62-12-20210204","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4244\/EIJV7I9A168","article-title":"Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial.","volume":"7","author":"Dudek","year":"2012","journal-title":"EuroIntervention"},{"key":"R63-12-20210204","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e3283587c7e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:53:58Z","timestamp":1620953638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201211000-00012"}},"subtitle":["current concepts"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283587c7e","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}